Toxicokinetic study of pyrrole adducts and its potential application for biological monitoring of 2,5-hexanedione subacute exposure

International Archives of Occupational and Environmental Health

Volumn 87, Issue 6, 2014, Pages 655-662

  Yin, Hong Yin ^a,b   Guo, Ying ^a   Song, Fu Yong ^a   Zeng, Tao ^a   Xie, Ke Qin ^a  

^a SHANDONG UNIVERSITY   (China)

^b Jinan Municipal Center for Disease Control and Prevention   (China)

Author keywords

2 5 Hexanedione; Biomarker; Pyrrole adducts; Serum; Toxicokinetic; Urine

Indexed keywords

2,5-HEXANEDIONE; ALKANONE; BIOLOGICAL MARKER; HEXANE; N-HEXANE; NEUROTOXIN; PYRROLE DERIVATIVE;

ANIMAL; AREA UNDER THE CURVE; BLOOD; ENVIRONMENTAL MONITORING; MALE; METABOLISM; RAT; SPECTROPHOTOMETRY; TOXICOKINETICS; URINE; WISTAR RAT;

ANIMALS; AREA UNDER CURVE; BIOLOGICAL MARKERS; ENVIRONMENTAL MONITORING; HEXANES; HEXANONES; MALE; NEUROTOXINS; PYRROLES; RATS; RATS, WISTAR; SPECTROPHOTOMETRY; TOXICOKINETICS;

EID: 84904891036     PISSN: 03400131     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00420-013-0907-4     Document Type: Article

References (31)

1. Alessio L, Berlin A, Dell'Orto A, Toffoletto F, Ghezzi I (1985) Reliability of urinary creatinine as a parameter used to adjust values of urinary biological indicators. Int Arch Occup Environ Health 55(2):99-106
2. Couri D, Abdel-Rahman MS, Hetland LB (1978) Biotransformation of n-hexane and methyl n-butyl ketone in guinea pigs and mice. Am Ind Hyg Assoc J 39(4):295-300. doi: 10.1080/0002889778507761
3. DeCaprio AP, O'Neill EA (1985) Alterations in rat axonal cytoskeletal proteins induced by in vitro and in vivo 2,5-hexanedione exposure. Toxicol Appl Pharmacol 78(2):235-247
4. DeCaprio AP, Olajos EJ, Weber P (1982) Covalent binding of a neurotoxic n-hexane metabolite: conversion of primary amines to substituted pyrrole adducts by 2,5-hexanedione. Toxicol Appl Pharmacol 65(3):440-450
5. DeCaprio AP, Strominger NL, Weber P (1983) Neurotoxicity and protein binding of 2,5-hexanedione in the hen. Toxicol Appl Pharmacol 68(2):297-307
6. DeCaprio AP, Kinney EA, Fowke JH (1997) Regioselective binding of 2,5-hexanedione to high-molecular-weight rat neurofilament proteins in vitro. Toxicol Appl Pharmacol 145(1):211-217. doi: 10.1006/taap 1997.8181
7. dos Santos CR, Meyer Passarelli MM, de Nascimento Souza E (2002) Evaluation of 2,5-hexanedione in urine of workers exposed to n-hexane in Brazilian shoe factories. J Chromatogr B Analyt Technol Biomed Life Sci 778(1-2):237-244
8. Fedtke N, Bolt HM (1986) Methodological investigations on the determination of n-hexane metabolites in urine. Int Arch Occup Environ Health 57(2):149-158
9. Fedtke N, Bolt HM (1987) The relevance of 4,5-dihydroxy-2-hexanone in the excretion kinetics of n-hexane metabolites in rat and man. Arch Toxicol 61(2):131-137
10. Genter St Clair MB, Amarnath V, Moody MA, Anthony DC, Anderson CW, Graham DG (1988) Pyrrole oxidation and protein cross-linking as necessary steps in the development of gamma-diketone neuropathy. Chem Res Toxicol 1(3):179-185
11. Graham DG, Anthony DC, Boekelheide K (1982) In vitro and in vivo studies of the molecular pathogenesis of n-Hexane neuropathy. Neurobehav Toxicol Teratol 4(6):629-634
12. Greenberg GN, Levine RJ (1989) Urinary creatinine excretion is not stable: a new method for assessing urinary toxic substance concentrations. J Occup Med 31(10):832-838
13. Johnson DJ, Lack L, Ibrahim S, Abdel-Rahman SM, Abou-Donia MB (1995) Protein-bound pyrroles in rat hair following subchronic intraperitoneal injections of 2,5-hexanedione. J Toxicol Environ Health 45(3):313-324. doi: 10.1080/15287399509531998
14. Kawai T, Mizunuma K, Yasugi T, Uchida Y, Ikeda M (1990) The method of choice for the determination of 2,5-hexanedione as an indicator of occupational exposure to n-hexane. Int Arch Occup Environ Health 62(5):403-408
15. Kessler W, Heilmaier H, Kreuzer P, Shen JH, Filser M, Filser JG (1990) Spectrophotometric determination of pyrrole-like substances in urine of rat and man: an assay for the evaluation of 2,5-hexanedione formed from n-hexane. Arch Toxicol 64(3):242-246
16. Manini P, Andreoli R, Mutti A, Bergamaschi E, Franchini I (1999) Determination of free and glucuronated hexane metabolites without prior hydrolysis by liquid- and gas-chromatography coupled with mass spectrometry. Toxicol Lett 108(2-3):225-231
17. Mattocks AR, White IN (1970) Estimation of metabolites of pyrrolizidine alkaloids in animal tissues. Anal Biochem 38(2):529-535
18. Mayan O, Teixeira JP, Pires AF (2001) Biological monitoring of n-hexane exposure in Portuguese shoe manufacturing workers. Appl Occup Environ Hyg 16(7):736-741. doi: 10.1080/10473220116711
19. Mayan O, Teixeira JP, Alves S, Azevedo C (2002) Urinary 2,5 hexanedione as a biomarker of n-hexane exposure. Biomarkers 7(4):299-305. doi: 10.1080/13547500210136796
20. Misumi J, Nagano M, Futatsuka M, Zhao W, Kudo M (1997) Different administration schedules of the same dose of 2,5-hexanedione influence the development of neuropathy and the toxicokinetics. Neurochem Res 22(1):27-32
21. Perbellini L, Brugnone F, Pastorello G, Grigolini L (1979) Urinary excretion of n-hexane metabolites in rats and humans. Int Arch Occup Environ Health 42(3-4):349-354
22. Perbellini L, Amantini MC, Brugnone F, Frontali N (1982) Urinary excretion of n-hexane metabolites. A comparative study in rat, rabbit and monkey. Arch Toxicol 50(3-4):203-215
23. Perbellini L, Mozzo P, Olivato D, Brugnone F (1990) "Dynamic" biological exposure indexes for n-hexane and 2,5-hexanedione, suggested by a physiologically based pharmacokinetic model. Am Ind Hyg Assoc J 51(7):356-362. doi: 10.1080/15298669091369781
24. Perbellini L, Pezzoli G, Brugnone F, Canesi M (1993) Biochemical and physiological aspects of 2,5-hexanedione: endogenous or exogenous product? Int Arch Occup Environ Health 65(1):49-52
25. Schaumburg HH, Spencer PS (1976) Degeneration in central and peripheral nervous systems produced by pure n-hexane: an experimental study. Brain 99(2):183-192
26. Shaw G, Hou ZC (1990) Bundling and cross-linking of intermediate filaments of the nervous system. J Neurosci Res 25(4):561-568. doi: 10.1002/jnr.490250414
27. Toutain PL, Bousquet-Melou A (2004) Plasma terminal half-life. J Vet Pharmacol Ther 27(6):427-439. doi: 10.1111/j.1365-2885.2004.00600.x
28. van Engelen JG, Rebel-de Haan W, Opdam JJ, Mulder GJ (1997) Effect of coexposure to methyl ethyl ketone (MEK) on n-hexane toxicokinetics in human volunteers. Toxicol Appl Pharmacol 144(2):385-395. doi: 10.1006/taap 1997.8149
29. Veulemans H, Van Vlem E, Janssens H, Masschelein R, Leplat A (1982) Experimental human exposure to n-Hexane. Study of the respiratory uptake and elimination, and of n-Hexane concentrations in peripheral venous blood. Int Arch Occup Environ Health 49(3-4):251-263
30. Yasui T, Zhao W, Misumi J, Aoki K, Shimaoka A, Kudo M (1995) Influence of different doses of methyl ethyl ketone on 2,5-hexanedione concentrations in the sciatic nerve, serum, and urine of rats. Sangyo Eiseigaku Zasshi 37(1):19-24
31. Zhu M, Spink DC, Yan B, Bank S, DeCaprio AP (1994) Formation and structure of cross-linking and monomeric pyrrole autoxidation products in 2,5-hexanedione-treated amino acids, peptides, and protein. Chem Res Toxicol 7(4):551-558